Normalization of the immunological microenvironment and sustained minimal residual disease negativity: do we need both for long-term control of multiple myeloma?

HIGHLIGHTS

• who: Giuseppe Bertuglia and colleagues from the Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy have published the article: Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?, in the Journal: (JOURNAL) of 11/Nov/2022
• what: In this review the authors focus on the components of the BM ME and their role in MM on the prognostic significance of MRD negativity and finally on the relative contribution of tumor plasma cell biology and BM . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.